Combining Atomoxetine with Alpha, 2 Receptor Agonists Treating ADHD
H. Niederhofer · Journal of Scientific Research and Reports · 2014
Aims: Atomoxetine (ATX) and Methylphenidate (MPH) are first line agents in treatment of Attention Deficit Hyperactivity disorder (ADHD). ATX focuses on the frontal lobe, where disattention is situated, MPH on the amygdala, where also hyperacticity is situated. Sometimes, especial...
Open access
Research Article
10.9734/JSRR/2014/8494